跳至主要内容
临床试验/KCT0000874
KCT0000874招募中未知

Discontinuation of Donepezil or Memantine in Extremely Severe Alzheimer`s Disease Patients : A 12-Week, Randomized, Multi-center Trial

Bobath Memorial Hospital0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
65(Year) 至 100(Year)(—)
性别
All

入选标准

  • 1. Patients fulfilling DSM-IV criteria for dementia
  • 2. Patients fulfilling NINCDS-ADRDA possible or probable AD (Alzheimer’s disease)
  • 3. aged between 65 to 100 years old
  • 4. caregiver who can give full information about patient should exist
  • 5. same antidementia and antipsychotic medications at least 2 months before study enrollment
  • 6. patients who can visit hospital at every follow up
  • 7. K-MMSE =5 and FAST score 6a or less

排除标准

  • 1. severe uncontrolled medical condition
  • 2. other degenerative brain diesase or psychiatric disease which can cause dementia
  • 3. 2 or more antidementia medication(excluding brain pill).
  • 4. patients or caregivers do not accept the study

研究者

发起方
Bobath Memorial Hospital

相似试验